417 related articles for article (PubMed ID: 17064348)
21. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Sobue G
Ann N Y Acad Sci; 2006 Nov; 1086():21-34. PubMed ID: 17185503
[TBL] [Abstract][Full Text] [Related]
22. Protection of murine neural progenitor cells by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin in the low nanomolar concentration range.
Wang G; Krishnamurthy K; Tangpisuthipongsa D
J Neurochem; 2011 May; 117(4):703-11. PubMed ID: 21395580
[TBL] [Abstract][Full Text] [Related]
23. [The role of heat shock proteins HSP90 in the response of immune cells to centimeter microwaves].
Glushkova OV; Novoselova EG; Khrenov MO; Novoselova TV; Cherenkov DA; Lunin SM; Fesenko EE
Biofizika; 2008; 53(1):93-9. PubMed ID: 18488507
[TBL] [Abstract][Full Text] [Related]
24. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.
Cao L; Fei L; Chang TT; DeLeo JA
J Neurochem; 2007 Jul; 102(2):408-19. PubMed ID: 17442043
[TBL] [Abstract][Full Text] [Related]
25. In the rostral ventrolateral medulla, the 70-kDa heat shock protein (HSP70), but not HSP90, confers neuroprotection against fatal endotoxemia via augmentation of nitric-oxide synthase I (NOS I)/protein kinase G signaling pathway and inhibition of NOS II/peroxynitrite cascade.
Li FC; Chan JY; Chan SH; Chang AY
Mol Pharmacol; 2005 Jul; 68(1):179-92. PubMed ID: 15827295
[TBL] [Abstract][Full Text] [Related]
26. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
[TBL] [Abstract][Full Text] [Related]
27. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
[TBL] [Abstract][Full Text] [Related]
28. Immune expression and inhibition of heat shock protein 90 in uveal melanoma.
Faingold D; Marshall JC; Antecka E; Di Cesare S; Odashiro AN; Bakalian S; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(3):847-55. PubMed ID: 18245548
[TBL] [Abstract][Full Text] [Related]
29. Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways.
Tichauer J; Saud K; von Bernhardi R
Neuroimmunomodulation; 2007; 14(3-4):168-74. PubMed ID: 18073510
[TBL] [Abstract][Full Text] [Related]
30. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
31. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury.
Gabrielson K; Bedja D; Pin S; Tsao A; Gama L; Yuan B; Muratore N
Cancer Res; 2007 Feb; 67(4):1436-41. PubMed ID: 17308081
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
Raghav SK; Gupta B; Shrivastava A; Das HR
Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
35. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.
McCollum AK; Teneyck CJ; Sauer BM; Toft DO; Erlichman C
Cancer Res; 2006 Nov; 66(22):10967-75. PubMed ID: 17108135
[TBL] [Abstract][Full Text] [Related]
37. Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.
Jayanthan A; Fowler J; Hawkins L; Lamers F; Teja B; Incoronato A; Anderson R; Narendran A
J Exp Ther Oncol; 2008; 7(3):183-93. PubMed ID: 19066127
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Hsp90 function delays and impairs recovery from heat shock.
Duncan RF
FEBS J; 2005 Oct; 272(20):5244-56. PubMed ID: 16218955
[TBL] [Abstract][Full Text] [Related]
39. Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
Francis LK; Alsayed Y; Leleu X; Jia X; Singha UK; Anderson J; Timm M; Ngo H; Lu G; Huston A; Ehrlich LA; Dimmock E; Lentzsch S; Hideshima T; Roodman GD; Anderson KC; Ghobrial IM
Clin Cancer Res; 2006 Nov; 12(22):6826-35. PubMed ID: 17121904
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
Al Shaer L; Walsby E; Gilkes A; Tonks A; Walsh V; Mills K; Burnett A; Rowntree C
Br J Haematol; 2008 May; 141(4):483-93. PubMed ID: 18373709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
